Objective  To investigate the current situation of randomized controlled trials or clinical controlled trial (RCT/CCT) on chronic hepatitis B and whether to offer reliable evidence for clinical practice in China. 
Methods  RCT/CCT identified from six Chinese clinical journals were searched manually and assessed according to international standard of evidence-based medicine. 
Results  308 issues containing 212 therapeutic articles and 88 RCT/CCT on chronic hepatitis B were identified and analyzed. 
Conclusion  the quantity and quality of RCT/CCT of chronic hepatitis B did not meet the need of clinical practice.
                                 
Citation: GUO Zhen,WANG Yiping,JIN ShuIi,ZHAO Pengcheng. Analysis of therapeutic articles on chronic hepatitis B in China. Chinese Journal of Evidence-Based Medicine, 2002, 02(2): 101-103. doi: Copy
Copyright ? the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved
 
        

 
                